Table 1.
Parameter | Methodology | Wavelength (nm) | CVa |
---|---|---|---|
Glucose | Endpoint | 510 | 1.50 |
Total cholesterol | Endpoint | 510 | 2.10 |
NEFAb | Endpoint | 546 | 1.50 |
BHBAc | Endpoint | 340 | 5.25 |
Urea | Endpoint | 340 | 1.20 |
Creatinine | Endpoint | 510 | 5.40 |
Ca | Endpoint | 570 | 1.40 |
Inorganig P | Endpoint | 340 | 2.00 |
Mg | Rate | 340 | 1.40 |
Na | ISE deviceg | 0.90 | |
K | ISE deviceg | 1.30 | |
Cl | ISE deviceg | 1.50 | |
Zn | Endpoint | 546 | |
Ceruloplasmin | Endpoint | 546 | 3.48 |
Total protein | Endpoint | 546 | 1.20 |
Albumin | Endpoint | 600 | 1.80 |
Total bilirubin | Endpoint | 546 | 6.70 |
Haptoglobin | Endpoint | 450 | 13.54 |
ASTd | Rate | 340 | 2.10 |
GGTe | Rate | 405 | 3.72 |
APf | Rate | 405 | 1.70 |
aCalculared on the results obtained between runs according to the National Committee for Clinical Laboratory Standards (Document EP3-T: Guidelines for Manufacturers for Establishing
Performance Claims for Clinical Chemistry Methods, Replication Experiment
Evaluation”, Villanova, PA, 1982.)
bNon esterified fatty acids;
cβ-OH-butyric acid;
dAspartate amino transferase
eγ-glutamyl transferase
fAlkaline phosphatase
gIon selective electrodes